Jason K. Garland
CIK: 0001754555
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REPLIGEN CORP
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 25, 2026RGEN
REPLIGEN CORP
Tax Payment(F)Direct421 shares at avg. $189.68$80K - Jul 16, 2026RGEN
REPLIGEN CORP
Sale(S)Direct530 shares at avg. $150.00$80K - Jun 25, 2026RGEN
REPLIGEN CORP
Sale(S)Direct733 shares at avg. $145.00$106K - Mar 5, 2026RGEN
REPLIGEN CORP
Award(A)Direct7.8K shares- - Mar 2, 2026RGEN
REPLIGEN CORP
Tax Payment(F)Direct715 shares at avg. $124.97$89K - Feb 27, 2026RGEN
REPLIGEN CORP
Tax Payment(F)Direct327 shares at avg. $128.73$42K - Sep 25, 2025RGEN
REPLIGEN CORP
Tax Payment(F)Direct412 shares at avg. $121.68$50K - Mar 3, 2025RGEN
REPLIGEN CORP
Award(A)Direct6.4K shares- - Feb 27, 2025RGEN
REPLIGEN CORP
Tax Payment(F)Direct316 shares at avg. $156.54$49K - Nov 20, 2024RGEN
REPLIGEN CORP
Tax Payment(F)Direct367 shares at avg. $123.41$45K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 25, 2026 | RGEN REPLIGEN CORP | Tax Payment(F) | 421 | $189.68 | $79,855 | Direct |
| Jul 16, 2026 | RGEN REPLIGEN CORP | Sale(S) | 530 | $150.00 | $79,500 | Direct |
| Jun 25, 2026 | RGEN REPLIGEN CORP | Sale(S) | 733 | $145.00 | $106,285 | Direct |
| Mar 5, 2026 | RGEN REPLIGEN CORP | Award(A) | 7,751 | - | $0 | Direct |
| Mar 2, 2026 | RGEN REPLIGEN CORP | Tax Payment(F) | 715 | $124.97 | $89,354 | Direct |
| Feb 27, 2026 | RGEN REPLIGEN CORP | Tax Payment(F) | 327 | $128.73 | $42,095 | Direct |
| Sep 25, 2025 | RGEN REPLIGEN CORP | Tax Payment(F) | 412 | $121.68 | $50,132 | Direct |
| Mar 3, 2025 | RGEN REPLIGEN CORP | Award(A) | 6,435 | - | - | Direct |
| Feb 27, 2025 | RGEN REPLIGEN CORP | Tax Payment(F) | 316 | $156.54 | $49,467 | Direct |
| Nov 20, 2024 | RGEN REPLIGEN CORP | Tax Payment(F) | 367 | $123.41 | $45,291 | Direct |
1-10 of 10 transactions
About Garland Jason K
Garland Jason K (SEC CIK 0001754555) files insider reports with the SEC as CFO of REPLIGEN CORP (RGEN).
Signal8 holds 9 ownership filings by Garland Jason K, all Form 4s, filed between Nov 21, 2024 and Sep 28, 2026. Those filings report 10 transactions, from Nov 20, 2024 to Sep 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Garland Jason K's filings is in WALTHAM, MA.
Recent filings by Garland Jason K
- Sep 25, 2026: Tax withholding of RGEN shares (Form 4, code F).
- Jul 16, 2026: Open-market sale of RGEN shares (Form 4, code S).
- Jun 25, 2026: Open-market sale of RGEN shares (Form 4, code S).
- Mar 5, 2026: Grant or award of RGEN shares (Form 4, code A).
- Mar 2, 2026: Tax withholding of RGEN shares (Form 4, code F).
Other insiders filing for REPLIGEN CORP (RGEN)
- Douglass Brian Robb, CHIEF PRODUCT OFFICER
- Loeillot Olivier, Chief Executive Officer
- Hughes Violetta, CHIEF ACCOUNTING OFFICER
- Madaus Martin D, Director
- Konstantinov Konstantin, Director
- Mhatre Rohin, Director